Correlation Between Pfizer and Scilex Holding

Can any of the company-specific risk be diversified away by investing in both Pfizer and Scilex Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Scilex Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Scilex Holding, you can compare the effects of market volatilities on Pfizer and Scilex Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Scilex Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Scilex Holding.

Diversification Opportunities for Pfizer and Scilex Holding

0.8

Correlation Coefficient

Pfizer  Scilex Holding

Very poor diversification

The 3 months correlation between Pfizer and Scilex is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Scilex Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scilex Holding and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Scilex Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scilex Holding has no effect on the direction of Pfizer i.e., Pfizer and Scilex Holding go up and down completely randomly.

Pair Corralation between Pfizer and Scilex Holding

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.2 times more return on investment than Scilex Holding. However, Pfizer Inc is 5.13 times less risky than Scilex Holding. It trades about -0.16 of its potential returns per unit of risk. Scilex Holding is currently generating about -0.13 per unit of risk. If you would invest  2,961  in Pfizer Inc on September 16, 2024 and sell it today you would lose (403.00) from holding Pfizer Inc or give up 13.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Scilex Holding

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Scilex Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scilex Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Pfizer and Scilex Holding

The main advantage of trading using opposite Pfizer and Scilex Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Scilex Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scilex Holding will offset losses from the drop in Scilex Holding's long position.

The idea behind Pfizer Inc and Scilex Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.